2018 Australasian Genomic Technologies Association conference
The Australasian Genomic Technologies Association (AGTA) conference, Australia’s foremost genomic technology conference, is an essential event for researchers and industry representatives who work with genomic technologies in a variety of contexts including platform development, medical genomics, functional genomics, non-model systems, epigenomics and plant genomics.
What: The 18th annual AGTA conference
Where: Stamford Grand Hotel in Glenelg, Adelaide
When: 4–7 November 2018
The AGTA conference covers all aspects of genomic science, technologies and their applications. This year’s event will cover a range of topics including cancer genomics, neurogenetics, bioinformatics, computational biology, plant and animal genomics, microbial and meta genomics, ancient DNA as well as highlights of emerging genomic technologies. The AGTA meeting attracts a diverse range of participants including researchers, service providers, industry representatives and students. The conference offers an important opportunity for computational biologists, bioinformaticians and data visualisation specialists to interact with technologists and biologists. This unique mix is one of the reasons that the Australian genomics community has a dynamic cross-disciplinary and innovative approach to genomic analysis, and is at the forefront of analysis tools for new types of ‘omics’ data.
Confirmed keynote speakers include:
- Elizabeth Dinsdale, San Diego State University
- Daniel Geschwind, University of California, Los Angeles
- Jim Haseloff, University of Cambridge
- Ludovic Orlando, University of Copenhagen
- Taru Tukiainen, University of Helsinki
- Kevin White, The University of Chicago
- Marlon Stoeckius, New York Genome Center
- Jacqueline Batley, The University of Western Australia
- Nicole Cloonan, University of Auckland
- Michael McDonald, Monash University
- Gene Tyson, The University of Queensland
- Nic Waddell, QIMR Berghofer
- Sally Ann Harbison, ESR
- Ryan Lister, The University of Western Australia
- Naomi Wray, The University of Queensland
Does China's leading place in the global medtech market reflect the reality?
To many healthcare buyers in the US, Europe, South-East Asia, Africa and South America, China...
Clinical Trial Transformation: Recent Changes and Future Predictions
Accelerated by the COVID-19 pandemic, we have seen a shift in clinical trials, with changes to...
International keynote to headline Accreditation Matters 2024
The landmark two-day conference will focus on the crucial role accreditation and conformity...
